55 East Monroe Street
Suite 3300
Chicago, Illinois 60603-5792

Daiichi Sankyo Cuts Executives’ Pay After $500 Million Ranbaxy Settlement

December 21, 2011
Bloomberg

Daiichi Sankyo Co. (4568) cut pay for executives and directors after slashing its profit forecast because of a $500 million provision to settle a legal dispute at its Ranbaxy Laboratories Ltd. unit in India.

Japan’s third-biggest drugmaker by market value expects net income to slump 63 percent to 26 billion yen ($334 million) in the year ending March 2012, from 70.1 billion yen a year earlier, it said in a statement today. Profit will miss the 50 billion yen forecast made in July because of a 37.5 billion yen charge linked to Ranbaxy’s settlement with the U.S. Justice Department, it said. To read the complete article click here.

Attorneys at law

 

resources

False claims act basics

Newsroom

Our successes

Our website uses cookies to improve your experience. By continuing to use this website, you are agreeing to our Cookie Policy.